|
⚲
|
| Keyboard |
| Bayer World Investments BV
✚
|
|
|---|---|
| CIK # | 0001820027 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001820027] | |
| 4 | [0001820027] | |
| SC 13G | [0001820027] |
| Form 13D/13G Filer | Form 13D/13G Subject | Filed |
|---|---|---|
| Bayer World Investments BV | Pyxis Oncology Inc | [2022-02-11] |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Senti Biosciences Holdings Inc SNTI
Series A Convertible Preferred Stock · derivative
|
2025-03-10 | Conversion | 2,222 | ||
|
Senti Biosciences Holdings Inc SNTI
Common Stock
|
2025-03-10 | Conversion | 2,222,000 | ||
|
Senti Biosciences Holdings Inc SNTI
Series A Convertible Preferred Stock · derivative
|
2024-12-09 | Buy | 2,222 | ||
|
Senti Biosciences Holdings Inc SNTI
Warrant · derivative
|
2024-12-09 | Buy | 3,333,000 | ||
|
Metagenomi Therapeutics Inc MGX
Common Stock
|
2024-02-13 | Conversion | 589,662 | ||
|
Metagenomi Therapeutics Inc MGX
Common Stock
|
2024-02-13 | Conversion | 1,180,592 | ||
|
Metagenomi Therapeutics Inc MGX
Common Stock
|
2024-02-13 | Conversion | 1,770,888 | ||
|
Metagenomi Therapeutics Inc MGX
Common Stock
|
2024-02-13 | Conversion | 509,855 | ||
|
Metagenomi Therapeutics Inc MGX
Series A-1 Convertible Preferred Stock · derivative
|
2024-02-13 | Conversion | 3,093,580 | $0.00 | |
|
Metagenomi Therapeutics Inc MGX
Series B-1 Convertible Preferred Stock · derivative
|
2024-02-13 | Conversion | 890,671 | $0.00 | |
|
Metagenomi Therapeutics Inc MGX
Series B Convertible Preferred Stock · derivative
|
2024-02-13 | Conversion | 1,030,086 | $0.00 | |
|
Metagenomi Therapeutics Inc MGX
Series A-4 Convertible Preferred Stock · derivative
|
2024-02-13 | Conversion | 2,062,387 | $0.00 | |
|
Azitra Inc AZTR
Common Stock
|
2023-06-21 | Conversion | 1,307,401 | ||
|
Azitra Inc AZTR
Series B Convertible Preferred Stock · derivative
|
2023-06-21 | Conversion | 1,307,401 | $0.00 | |
|
Pyxis Oncology Inc PYXS
Common Stock
|
2021-10-13 | Conversion | 2,742,338 | ||
|
Pyxis Oncology Inc PYXS
Series A Convertible Preferred Stock · derivative
|
2021-10-13 | Conversion | 11,362,462 | ||
|
Pyxis Oncology Inc PYXS
Series B Convertible Preferred Stock · derivative
|
2021-10-13 | Conversion | 6,076,072 | ||
|
Century Therapeutics Inc IPSC
Common Stock
|
2021-06-22 | Buy | 750,000 | $20.00 | 15,000,000 |
|
Century Therapeutics Inc IPSC
Common Stock
|
2021-06-22 | Conversion | 1,535,238 | ||
|
Century Therapeutics Inc IPSC
Common Stock
|
2021-06-22 | Conversion | 10,390,600 | ||
| showing 20 of 23 most recent transactions | |||||